Get the app
US › Healthcare

Satellos Bioscience Inc. Common Stock (MSLE)

US · Healthcare · Biotechnology

$6.46-5.56%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-11.4M
EPS
$-0.56
EPS estimate
$-0.38

EPS came in at -0.56 against a street estimate of -0.38 — a miss of 47.4%.

Key statistics

Market cap
$149.4M
Forward P/E
0.0
P/B
3.04
Book value
$2.88
EPS (TTM)
$-1.95
52-week high
$13.39
52-week low
$5.30
50-day MA
$9.20
200-day MA
$8.48
Beta
1.15

Analyst view

Analysts rate Satellos Bioscience Inc. Common Stock a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $24.17.

Shareholding

Insiders
6.37%
Institutions
49.70%

Largest institutional holders

FundStake
Franklin Templeton Inc4.42%
Siren, L.L.C.4.20%
Vivo Capital, LLC3.84%
Point72 Asset Management, L.P.3.22%
Sphera Funds Management Ltd.3.08%
Woodline Partners LP2.36%
Stonepine Capital Management Llc2.32%
Suvretta Capital Management, LLC2.24%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Satellos Bioscience Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.